a clinical-stage biopharmaceutical company which develops novel immunotherapy''s
Industry Biotechnology
A.I.dvisor indicates that over the last year, MBIO has been closely correlated with SLRX. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MBIO jumps, then SLRX could also see price increases.
Ticker / NAME | Correlation To MBIO | 1D Price Change % | ||
---|---|---|---|---|
MBIO | 100% | -3.14% | ||
SLRX - MBIO | 71% Closely correlated | -2.90% | ||
MDGL - MBIO | 50% Loosely correlated | -4.66% | ||
ORMP - MBIO | 44% Loosely correlated | -4.50% | ||
AXON - MBIO | 40% Loosely correlated | -0.86% | ||
SCNI - MBIO | 38% Loosely correlated | -4.36% | ||
More |